Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
公司代码BVS
公司名称Bioventus Inc
上市日期Feb 11, 2021
CEOClaypoole (Robert E)
员工数量930
证券类型Ordinary Share
年结日Feb 11
公司地址4721 Emperor Boulevard, Suite 100
城市DURHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编27703
电话19194746700
网址https://www.bioventus.com/
公司代码BVS
上市日期Feb 11, 2021
CEOClaypoole (Robert E)